Paloma Gijón

TL;DR: A large series of patients with chronic obstructive pulmonary disease and probable invasive pulmonary aspergillosis (IPA) are described, and the risk factors and incidence of the disease in patients with isolation of Aspergillus from lower respiratory tract samples are described.

TL;DR: Clinicians should consider adequate empirical therapy with coverage of these pathogens for patients with risk factors, including ESBLEC, which is an important cause of COBSI due to E. coli.

TL;DR: It is concluded that ESBLEC is an important cause of nosocomial BSIs and the previous use of oxyimino-β-lactams was the only modifiable risk factor found.

TL;DR: MycAssay™ Aspergillus showed high sensitivity for the diagnosis of invasive aspergillosis in patients without hematological cancer and compared with fungal culture, PCR significantly reduced the time to diagnosis.

TL;DR: The presence of Aspergillus antigens in blood transfusion components from different manufacturers was analyzed and galacomannans were found in transfused patients, pooled platelet concentrates, fresh frozen plasma, and packed red cells collected using Fresenius Kabi bags.